4//SEC Filing
Kraws Jeffrey J 4
Accession 0001104659-25-043507
CIK 0000894158other
Filed
Apr 30, 8:00 PM ET
Accepted
May 1, 4:01 PM ET
Size
5.7 KB
Accession
0001104659-25-043507
Insider Transaction Report
Form 4
Kraws Jeffrey J
Director
Transactions
- Award
Stock Options (right to buy)
2025-04-29+25,000→ 25,000 totalExercise: $1.41From: 2025-05-01Exp: 2032-04-29→ Common Stock (25,000 underlying)
Footnotes (1)
- [F1]These stock options vest pro rata on a monthly basis over 12 months.
Documents
Issuer
Theriva Biologics, Inc.
CIK 0000894158
Entity typeother
Related Parties
1- filerCIK 0001380918
Filing Metadata
- Form type
- 4
- Filed
- Apr 30, 8:00 PM ET
- Accepted
- May 1, 4:01 PM ET
- Size
- 5.7 KB